What’s going on here? Australian biotech PYC Therapeutics raised AU$537 million from institutional investors at AU$1.50 a share and expects at least AU$600 million total once its retail offer ends Feb ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as ...

Last month, heart device play Anteris Technologies (ASX:AVR) launched a US$320 million ($460m) capital raise and strategic tie-up with Medtronic. Today, PYC Therapeutics (ASX:PYC) upped the ante by ...

This raise will set the company up for years. With PYC's value sitting at $944.8 million at the close of trade on Friday, the raise will grow the size of the company by 69.2% in one fell swoop. The ...

PYC is serving heartbreak and honey in his long-awaited debut album, taste. A lush alt-pop journey through the highs and crashes of romance, taste dives deep into love’s many flavours — from dopamine ...

Game decompilations have been in the news on and off again for quite some time. It’s the act of reverse engineering games to run natively on PC (or any hardware, in theory). Now, there’s potential for ...

Hold on tight as PYC drops his debut album taste depicting romance as a rollercoaster full of ups and downs, sharp turns, and heart-racing moments. Get addicted to the thrill of the danger, sweetness, ...

Abstract: Python is one of the most popular programming languages among both industry developers and malware authors. Despite demand for Python decompilers, community efforts to maintain automatic ...

We feel now is a pretty good time to analyse PYC Therapeutics Limited's (ASX:PYC) business as it appears the company may be on the cusp of a considerable accomplishment. PYC Therapeutics Limited, a ...